| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 16,030 | $30 | $544.9K |
| J3262 | Injection, tocilizumab, 1 mg | 85,440 | $10 | $427.2K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 12,350 | $30 | $321.1K |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 68,000 | $1 | $272K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 13,900 | $10 | $152.9K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 790 | $90 | $71.2K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 650 | $100 | $61.5K |
| J0897 | Injection, denosumab, 1 mg | 2,220 | $20 | $40K |
| J3304 | Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg | 2,300 | $10 | $30K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 450 | $50 | $24.5K |